Deutsche Bank’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,354
| Closed | -$335K | – | 3680 |
|
|
2025
Q1 | $335K | Sell |
34,354
-167
| -0.5% | -$1.63K | ﹤0.01% | 2669 |
|
|
2024
Q4 | $436K | Sell |
34,521
-1,160
| -3% | -$14.7K | ﹤0.01% | 2644 |
|
|
2024
Q3 | $574K | Sell |
35,681
-80,887
| -69% | -$1.3M | ﹤0.01% | 2346 |
|
|
2024
Q2 | $2.84M | Buy |
116,568
+80,379
| +222% | +$1.96M | ﹤0.01% | 1453 |
|
|
2024
Q1 | $2.6M | Sell |
36,189
-80
| -0.2% | -$5.75K | ﹤0.01% | 1518 |
|
|
2023
Q4 | $7.21M | Buy |
36,269
+34,320
| +1,761% | +$6.82M | ﹤0.01% | 1110 |
|
|
2023
Q3 | $259K | Sell |
1,949
-34,105
| -95% | -$4.53M | ﹤0.01% | 2580 |
|
|
2023
Q2 | $5.39M | Sell |
36,054
-933
| -3% | -$140K | ﹤0.01% | 1206 |
|
|
2023
Q1 | $5.43M | Buy |
36,987
+1,220
| +3% | +$179K | ﹤0.01% | 1207 |
|
|
2022
Q4 | $5.67M | Buy |
35,767
+21
| +0.1% | +$3.33K | ﹤0.01% | 1171 |
|
|
2022
Q3 | $6.88M | Sell |
35,746
-393
| -1% | -$75.6K | ﹤0.01% | 1094 |
|
|
2022
Q2 | $5.28M | Buy |
36,139
+97
| +0.3% | +$14.2K | ﹤0.01% | 1251 |
|
|
2022
Q1 | $6.34M | Sell |
36,042
-2,937
| -8% | -$517K | ﹤0.01% | 1290 |
|
|
2021
Q4 | $11.5M | Buy |
38,979
+37,130
| +2,008% | +$10.9M | 0.01% | 1043 |
|
|
2021
Q3 | $460K | Buy |
1,849
+256
| +16% | +$63.7K | ﹤0.01% | 3076 |
|
|
2021
Q2 | $405K | Sell |
1,593
-7,027
| -82% | -$1.79M | ﹤0.01% | 3337 |
|
|
2021
Q1 | $1.53M | Buy |
8,620
+5,647
| +190% | +$1M | ﹤0.01% | 2367 |
|
|
2020
Q4 | $470K | Buy |
2,973
+2,211
| +290% | +$350K | ﹤0.01% | 2925 |
|
|
2020
Q3 | $196K | Buy |
762
+67
| +10% | +$17.2K | ﹤0.01% | 3191 |
|
|
2020
Q2 | $162K | Buy |
695
+634
| +1,039% | +$148K | ﹤0.01% | 3191 |
|
|
2020
Q1 | $10K | Sell |
61
-4
| -6% | -$656 | ﹤0.01% | 3925 |
|
|
2019
Q4 | $14K | Buy |
+65
| New | +$14K | ﹤0.01% | 4214 |
|